ProCE Banner Activity

Considering Long-acting ART With Viremia and Past Adherence Challenges

Podcast Episodes

Listen as Drs Aadia Rana and Laurence Slama discuss the subtleties of deciding among HIV treatment options in people with adherence challenges. They explore resistance considerations, recommendations concerning proviral DNA genotyping, and how to interpret guidelines for long-acting ART in this population, including its potential risks and benefits. 

Released: August 29, 2024

Expiration: August 28, 2025

Share

Faculty

Aadia I. Rana

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Laurence Slama

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu University Hospital
University Paris Cité
Paris, France

Provided by

Provided by Clinical Care Options, LLC, in partnership with HIV-ASSIST

ProCE Banner

Supporters

Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Partners

HIV-ASSIST

ProCE Banner

Disclosure

Primary Author

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Aadia I. Rana, MD, has no relevant financial relationships to disclose.

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu University Hospital
University Paris Cité
Paris, France

Laurence Slama, MD, PhD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, ViiV.